Experts to search for lost Progress spacecraft’s fragments in SiberiaScience & Space December 06, 23:57
Russian opera prima donna nominated for Grammy 2017 awardSociety & Culture December 06, 23:46
Russian pediatrician wounded in Aleppo flown to MoscowWorld December 06, 23:35
Putin looks forward to overcoming negative trends in turnover with TurkeyBusiness & Economy December 06, 21:20
Red Cross to continue humanitarian operations in Aleppo — spokespersonWorld December 06, 21:09
Russia proposes UN to be venue for discussing world’s controversial anti-doping systemSport December 06, 21:04
Dialogue on Germany’s initiative for armed control depends on NATO — diplomatRussian Politics & Diplomacy December 06, 20:57
Mikhail Saakashvili says he seeks to change Ukraine’s political classWorld December 06, 20:46
Defense minister promises 2017 World Military Games in Sochi to be held 'at highest level'Military & Defense December 06, 20:37
GENEVA, July 11. /TASS/. The Court of Arbitration for Sport (CAS) in Lausanne will issue the decision on Russian tennis player Maria Sharapova’s case by September 19.
In the statement published on the court’s official website on Monday, CAS said: "In her appeal to the CAS, Ms Sharapova seeks the annulment of the Tribunal’s decision to sanction her with a two-year period of ineligibility further to an anti-doping rule violation. Ms Sharapova submits that the period of ineligibility should be eliminated, or in the alternative, reduced. The final decision will be announced and published by CAS when it is available."
Consequently, Sharapova will miss 2016 Summer Olympic Games in Rio de Janeiro that will take place on August 5-21.
The fact that Russian tennis player Maria Sharapova will miss 2016 Summer Olympic Games in Rio de Janeiro is a great loss for the national team, President of the Russian Tennis Federation Shamil Tarpishchev told TASS on Monday.
"Sharapova’s absence is a loss for our national team at the Olympics. We hoped for her medal in singles. In the current situation, the composition of the women’s team at the Games remains unchanged," Tarpishchev said.
The RTF stated in late May that it decided to enter in the Olympic team Sharapova, Svetlana Kuznetsova, Anastasia Pavliuchenkova and Darya Kasatkina.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on World Anti-Doping Agency's (WADA) blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.